Articles
Novel Pharmacologic Treatments for Cardiovascular Disease: A Practical Update
Citation:
US Cardiology Review 2017;11(2):98–104.
Left Ventricular Assisting Devices in Percutaneous Coronary Intervention
Citation:
US Cardiology Review 2017;11(2):86–94.
The Impact of an Atrial Septal Defect on Hemodynamics in Patients With Heart Failure
Citation:
US Cardiology Review 2017;11(2):72–4.
Clinical Trial Perspective: Optimizing Crossover From Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome (CAPITAL OPTICROSS)
Citation:
US Cardiology Review 2017;11(2):59–61.
Controversies in Antiplatelet and Anticoagulation Therapy in Patients Presenting with Acute Coronary Syndrome
Citation:
US Cardiology Review 2017;11(2):52–8.
Guest Editorial: A Brave New World for Non-vitamin K Antagonist Oral Anticoagulants: Have We seen the Last of Warfarin?
Citation:
US Cardiology Review 2017; 11(1):37–8
Guest Editorial: Commentary on the Findings of the GLAGOV Randomized Clinical Trial
Citation:
US Cardiology Review 2017;11(1):18–9
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease
Citation:
US Cardiology Review 2017;11(1):16–7